Showing results (1401-1410 of 1,724) with videos related to

Sort By:
Pageof 173
Endocrinology|December 1, 1987
Thymosin fraction 5 stimulates prolactin and growth hormone release from anterior pituitary cells in vitroB L Spangelo, A M Judd, P C Ross, et al.
International Journal of Antimicrobial Agents|February 14, 2026
Urine NGAL Adds to Serum Creatinine in Predicting Cefepime Clearance in Critically Ill Children at High Risk of Acute Kidney InjuryH Rhodes Hambrick, Ronaldo Morales Junior, Calise Curry, et al.
Journal of the American College of Cardiology|December 27, 2014
Combining functional and tubular damage biomarkers improves diagnostic precision for acute kidney injury after cardiac surgeryRajit K Basu, Hector R Wong, Catherine D Krawczeski, et al.
The American Journal of Gastroenterology|August 5, 2000
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitorJ L Goldstein, F E Silverstein, N M Agrawal, et al.
Annals of Internal Medicine|February 1, 1984
Antibody to human T-cell leukemia virus membrane antigens, beta 2-microglobulin levels, and thymosin alpha 1 levels in hemophiliacs and their spousesJ K Kreiss, D N Lawrence, C K Kasper, et al.
Plos One|June 1, 2013
Separate populations of neurons in ventral striatum encode value and motivationGregory B Bissonette, Amanda C Burton, Ronny N Gentry, et al.
Pediatric Cardiology|January 9, 2026
Practice Patterns and Outcomes of Hemodialysis in Infants Undergoing Congenital Heart Surgery in the United StatesGrant Chappell, Darren Turner, Amir Mehdizadeh-Shrifi, et al.
Alimentary Pharmacology & Therapeutics|July 19, 2012
Risk factors associated with a decrease ≥2 g/dL in haemoglobin and/or ≥10% haematocrit in osteoarthritis patients taking celecoxib or a nonselective NSAID plus a PPI in a large randomised controlled trial (CONDOR)A Lanas, J L Goldstein, F K L Chan, et al.
Kidney Medicine|April 5, 2024
Selective Cytopheretic Device Use in Continuous Kidney Replacement Therapy in Children: A Cohort Study With a Historical ComparatorStuart L Goldstein, Nicholas J Ollberding, David J Askenazi, et al.
Journal of Biological Response Modifiers|April 1, 1985
A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancerR S Schulof, M J Lloyd, P A Cleary, et al.
Pageof 173